Cite
Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.
MLA
Park, Ji Eun, et al. “Amide Proton Transfer Imaging Seems to Provide Higher Diagnostic Performance in Post-Treatment High-Grade Gliomas than Methionine Positron Emission Tomography.” European Radiology, vol. 28, no. 8, Aug. 2018, pp. 3285–95. EBSCOhost, https://doi.org/10.1007/s00330-018-5341-2.
APA
Park, J. E., Lee, J. Y., Kim, H. S., Oh, J.-Y., Jung, S. C., Kim, S. J., Keupp, J., Oh, M., & Kim, J. S. (2018). Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography. European Radiology, 28(8), 3285–3295. https://doi.org/10.1007/s00330-018-5341-2
Chicago
Park, Ji Eun, Ji Ye Lee, Ho Sung Kim, Joo-Young Oh, Seung Chai Jung, Sang Joon Kim, Jochen Keupp, Minyoung Oh, and Jae Seung Kim. 2018. “Amide Proton Transfer Imaging Seems to Provide Higher Diagnostic Performance in Post-Treatment High-Grade Gliomas than Methionine Positron Emission Tomography.” European Radiology 28 (8): 3285–95. doi:10.1007/s00330-018-5341-2.